BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17445916)

  • 1. Mood and male sexual behaviour in the APP23 model of Alzheimer's disease.
    Vloeberghs E; Van Dam D; Franck F; Staufenbiel M; De Deyn PP
    Behav Brain Res; 2007 Jun; 180(2):146-51. PubMed ID: 17445916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances.
    Vloeberghs E; Van Dam D; Engelborghs S; Nagels G; Staufenbiel M; De Deyn PP
    Eur J Neurosci; 2004 Nov; 20(10):2757-66. PubMed ID: 15548219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression model.
    Vloeberghs E; Van Dam D; Franck F; Serroyen J; Geert M; Staufenbiel M; De Deyn PP
    Behav Neurosci; 2008 Jun; 122(3):491-7. PubMed ID: 18513119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APP23 mice display working memory impairment in the plus-shaped water maze.
    Vloeberghs E; Van Dam D; D'Hooge R; Staufenbiel M; De Deyn PP
    Neurosci Lett; 2006 Oct; 407(1):6-10. PubMed ID: 16959424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation.
    Dumont M; Strazielle C; Staufenbiel M; Lalonde R
    Brain Res; 2004 Oct; 1024(1-2):113-21. PubMed ID: 15451372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
    Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
    Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive male APP23 mice modeling behavioral alterations in dementia.
    Vloeberghs E; Van Dam D; Coen K; Staufenbiel M; De Deyn PP
    Behav Neurosci; 2006 Dec; 120(6):1380-3. PubMed ID: 17201483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?
    Richter H; Ambrée O; Lewejohann L; Herring A; Keyvani K; Paulus W; Palme R; Touma C; Schäbitz WR; Sachser N
    Behav Brain Res; 2008 Jun; 190(1):74-84. PubMed ID: 18342378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Rattray I; Scullion GA; Soulby A; Kendall DA; Pardon MC
    Behav Brain Res; 2009 Jun; 200(1):83-90. PubMed ID: 19162086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the APP23 transgenic mouse model of Alzheimer's disease through evaluation of risperidone treatment on aggressive behaviour.
    Vloeberghs E; Coen K; Van Dam D; De Deyn PP
    Arzneimittelforschung; 2008; 58(6):265-8. PubMed ID: 18677967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene.
    Barnes P; Good M
    Behav Brain Res; 2005 Feb; 157(1):107-17. PubMed ID: 15617777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Genes Brain Behav; 2009 Mar; 8(2):143-8. PubMed ID: 19077180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related impairments in operant DMTP performance in the PS2APP mouse, a transgenic mouse model of Alzheimer's disease.
    Woolley ML; Ballard TM
    Behav Brain Res; 2005 Jun; 161(2):220-8. PubMed ID: 15922048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease.
    Alexander G; Hanna A; Serna V; Younkin L; Younkin S; Janus C
    Behav Brain Res; 2011 Jan; 216(1):77-83. PubMed ID: 20655336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen.
    Lalonde R; Dumont M; Staufenbiel M; Strazielle C
    Behav Brain Res; 2005 Feb; 157(1):91-8. PubMed ID: 15617775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
    Pietropaolo S; Feldon J; Yee BK
    Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice.
    Szot P; Van Dam D; White SS; Franklin A; Staufenbiel M; De Deyn PP
    Neurosci Lett; 2009 Sep; 463(1):93-7. PubMed ID: 19631722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA.
    Senechal Y; Prut L; Kelly PH; Staufenbiel M; Natt F; Hoyer D; Wiessner C; Dev KK
    Brain Res; 2008 Dec; 1243():124-33. PubMed ID: 18823960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.